Levofloxacin secretion in breast milk: A case report

Pharmacotherapy

Volumn 25, Issue 1, 2005, Pages 116-118

  Cahill Jr , John B ^a,d   Bailey, Elaine M ^b   Chien, Shuchean ^c   Johnson, George M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Ortho McNeil Pharmaceutical Incorporated   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Breast milk; Fluoroquinolones; Levofloxacin; Pediatric exposure

Indexed keywords

LEVOFLOXACIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BREAST MILK; CASE REPORT; COMPARTMENT MODEL; CONCENTRATION RESPONSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG TISSUE LEVEL; EVALUATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT FEEDING; LACTATION; STEADY STATE;

ADMINISTRATION, ORAL; ADULT; BREAST FEEDING; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MILK, HUMAN; OFLOXACIN; RISK ASSESSMENT;

EID: 11144232506     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.25.1.116.55616     Document Type: Article

References (9)

1. Ito S. Drug therapy for breast-feeding women. N Engl J Med 2000;343:118-26.
2. Ito S, Lee A. Drug excretion into breast milk-overview. Adv Drug Deliv Rev 2003;55:617-27.
3. Chong AM, Reed MD, Blumer JL. Antibiotics and breastfeeding: a critical review of the literature. Paediatr Drugs 2002;4:817-37.
4. Takizawa T, Hashimoto K, Minami T, Yamashita S, Owen K. The comparative arthropathy of fluoroquinolones in dogs. Hum Exp Toxicol 1999;18:392-9.
5. Warren RW. Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones. Pediatr Infect Dis J 1997;16:118-22.
6. Ortho-McNeil Pharmaceutical. Levaquin (levofloxacin) product information (tablets and injection). Raritan, NJ, 2003.
7. Giamarellou H, Kolokythas E, Petrikkos G, Gazis J, Aravantinos K, Sfikakis P. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989;87:49S-51.
8. Preston SL, Drusano GL, Herman AL, et al. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA 1998;279:125-9.
9. Chien S, Abels R, Blumer J, et al. Single-dose pharmacokinetics and tolerability of intravenous levofloxacin in pediatric patients [abstr]. In: Program and abstracts of the 41st international conference on antimicrobial agents and chemotherapy. Washington, DC: American Society for Microbiology, 2001:7.